Latest Partnerships News

dorsaVi’s Q3 FY25 report reveals growing adoption of its AI-powered video movement analysis in the US, a new elite athlete research partnership, and the launch of a pioneering 3D ACL injury prevention test.

FirstWave’s Q3 FY25 update reveals steady contract renewals alongside tighter cash reserves, as the cybersecurity firm advances strategic partnerships and operational efficiencies.

FirstWave Cloud Technology reported a mixed Q3 FY25 with declining cash reserves and ARR but secured a strategic AWS-funded partnership to accelerate cloud service adoption.

Fenix Resources’ off-market takeover offer for CZR Resources has officially lapsed after failing to meet the 75% minimum acceptance threshold, leaving CZR shareholders in control of their stakes.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

Novonix Limited advances its synthetic graphite production with Riverside commissioning and a new Chattanooga plant site, while winning a preliminary US trade case against Chinese imports and appointing Michael O’Kronley as CEO.

Critical Minerals Group (CMG) advances its integrated vanadium flow battery strategy targeting commercial energy storage solutions by 2026, alongside key project and executive developments.

Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Pure Hydrogen Corporation has marked significant progress in its clean energy transition, delivering Australia's first hydrogen fuel cell garbage truck and securing multi-million dollar contracts with industry leaders TOLL Transport and Heidelberg Materials.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Australian Rare Earths Limited (ASX: AR3) has successfully raised $3.6 million through a fully subscribed rights issue, backed strongly by existing shareholders and directors. The capital injection positions AR3 to advance uranium exploration and rare earth development amid favorable geopolitical shifts.